Henri Leinonen, Associate Professor, University of Eastern Finland

Henri Leinonen, Associate Professor, University of Eastern Finland

Title history
  • Henri Leinonen, Associate Professor, University of Eastern Finland — observed on 20261028-0743 UTC (YouTube)

by Henri Leinonen · View the channel on PSI

Life & Natural Systems Science — General & History PDScience: general issuesPDMScientific research
🎙 Henri Leinonen 👥 1K 📅 October 28, 2026 ⏱ 21 min 👁 2 📄 expert opinion 🧭 2026-10-28
Available in: English (current) Français

Keywords

retinahomeostatic plasticityphotoreceptor degenerationdrug repurposingdopamine

Summary

Henri Leinonen presents the retina as an accessible model for studying neural circuit plasticity and neuropharmacology. He highlights the retina’s advantages: it can be excised and stained entirely, stimulated with precise patterns, and its output measured easily. He distinguishes experience-dependent plasticity (e.g., critical periods) from homeostatic plasticity, which maintains signaling at set points. His first research program investigates how photoreceptor degeneration triggers compensatory rewiring in surviving retinal circuits, using the P23H mouse model. They found that despite significant rod loss, bipolar cell responses and behavioral vision under photopic conditions remain compensated, but fail in dark conditions. They aim to understand the molecular mechanisms via laser-capture microdissection and ultra-high-resolution proteomics of the first visual synapse. His second program focuses on pharmacological neuroprotection by repurposing drugs. They observed elevated retinal dopamine levels in degenerating retinas, with COMT upregulation as the main clearance mechanism. A triple-drug combination (tamsulosin, metoprolol, and bromocriptine) targeting adrenergic and dopaminergic receptors improved cone signaling and visual acuity in mice. The talk includes a target engagement experiment showing PKA inhibition by the combination. Leinonen concludes that understanding surviving tissue changes enables better therapeutic targeting.

185 words

Critical Evaluation

Value of the Information & Strength of the Argument

The talk provides valuable insights into the retina as a model system and presents novel data on compensatory plasticity and drug repurposing. The argumentation is solid, built on specific experimental observations (e.g., ERG responses, behavioral tests, target engagement) and logical reasoning. Leinonen clearly separates adaptive versus maladaptive plasticity and connects molecular findings to functional outcomes. The use of a triple-drug combination rationalized by dopamine homeostasis is a thoughtful approach, though he acknowledges limitations such as lack of acute effects and complexity of monotherapy. The inclusion of a target engagement experiment strengthens the mechanistic claim.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high: the speaker uses established methods (electroretinography, optomotor reflex, pharmacology) and references a recent NEJM paper on prosthetic vision. However, the talk does not provide full citations or detailed methodological descriptions, typical for a conference presentation. The title is merely the speaker’s identity, which is not descriptive but do not detract from the content’s quality. The talk is well-structured and the experimental evidence is presented coherently.

179 words

Title / Content Match

The title is simply the speaker's name and affiliation, which does not describe the content. Nevertheless, the talk is a scientific presentation on retinal plasticity and neuropharmacology, consistent with the speaker's expertise.

Quality & Reliability

8/10

The speaker is an associate professor with expertise in retinal pharmacology, presents specific experimental data and references recent literature (e.g., NEJM paper). However, detailed source citations and methodological transparency are limited in the talk.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Cited Sources

  • Recent NEJM paper on prosthetic vision restoring sight — Mentioned as motivating the question of whether re-opening plasticity windows is needed after long-term blindness.
  • Paper by another group applying TTX to inactivate rods — Independent replication of the finding that inner retinal responses remain unchanged despite reduced rod input.
  • Hubel and Wiesel's studies on critical period plasticity — Historical context for experience-dependent plasticity, although not the focus of the talk.

Contribution & Novelties

The talk presents original findings on how the retina compensates for photoreceptor loss and how pharmacological manipulation of dopamine signaling can preserve function. The use of a triple-drug combination targeting multiple receptors is a novel approach to enhance efficacy. The ongoing proteomic analysis of the first visual synapse will provide molecular insights into plasticity. The work bridges basic neuroscience and potential clinical applications for retinal degeneration.

Pour aller plus loin :

  • Homeostatic plasticity — Relevant to the concept of stabilizing neural activity.
  • Retina — Overview of retinal structure and function.
  • Dopamine — Background on dopamine signaling relevant to the pharmacological interventions discussed.

102 words

Radar Profile

The scores reveal a balanced profile with high technical content and good reliability, while information quality is slightly lower due to the presentation format lacking detailed citations. The overall high scores reflect the speaker's expertise and the coherent presentation of ongoing research.

Reliability 8/10